Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
Authors: D. Revicki, M.K. Willian, J.-H. Saurat, K.A. Papp, J.-P. Ortonne, C. Sexton, A. Camez
Journal: British Journal of Dermatology (2007)

Journal Article Impact of adalimumab treatment on health‐related quality of life and other patient‐reported outcomes: results from a 16‐week randomized controlled trial in patients with moderate to severe plaque psoriasis Get access D. Revicki, D. Revicki Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, U.S.A. *Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, U.S.A. †Hôpital Cantonal Universitaire, Geneva, Switzerland ‡Probity Medical Research, Waterloo, ON, Canada §Hôpital l’Archet 2, Nice, France ¶Abbott GmbH & Co. KG, Ludwigshafen, Germany Correspondence: D. Revicki. E‐mail: dennis.revicki@unitedbiosource.com Search for other works by this author on: Oxford Academic Google Scholar M.K. Willian, M.K. Willian Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, U.S.A. *Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, U.S.A. †Hôpital Cantonal Universitaire, Geneva, Switzerland ‡Probity Medical Research, Waterloo, ON, Canada §Hôpital l’Archet 2, Nice, France ¶Abbott GmbH & Co. KG, Ludwigshafen, Germany Search for other works by this author on: Oxford Academic Google Scholar J.‐H. Saurat, J.‐H. Saurat Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, U.S.A. *Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, U.S.A. †Hôpital Cantonal Universitaire, Geneva, Switzerland ‡Probity Medical Research, Waterloo, ON, Canada §Hôpital l’Archet 2, Nice, France ¶Abbott GmbH & Co. KG, Ludwigshafen, Germany Search for other works by this author on: Oxford Academic Google Scholar K.A. Papp, K.A. Papp Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, U.S.A. *Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, U.S.A. †Hôpital Cantonal Universitaire, Geneva, Switzerland ‡Probity Medical Research, Waterloo, ON, Canada §Hôpital l’Archet 2, Nice, France ¶Abbott GmbH & Co. KG, Ludwigshafen, Germany Search for other works by this author on: Oxford Academic Google Scholar J.‐P. Ortonne, J.‐P. Ortonne Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, U.S.A. *Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, U.S.A. †Hôpital Cantonal Universitaire, Geneva, Switzerland ‡Probity Medical Research, Waterloo, ON, Canada §Hôpital l’Archet 2, Nice, France ¶Abbott GmbH & Co. KG, Ludwigshafen, Germany Search for other works by this author on: Oxford Academic Google Scholar C. Sexton, C. Sexton Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, U.S.A. *Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, U.S.A. †Hôpital Cantonal Universitaire, Geneva, Switzerland ‡Probity Medical Research, Waterloo, ON, Canada §Hôpital l’Archet 2, Nice, France ¶Abbott GmbH & Co. KG, Ludwigshafen, Germany Search for other works by this author on: Oxford Academic Google Scholar A. Camez A. Camez Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, U.S.A. *Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, U.S.A. †Hôpital Cantonal Universitaire, Geneva, Switzerland ‡Probity Medical Research, Waterloo, ON, Canada §Hôpital l’Archet 2, Nice, France ¶Abbott GmbH & Co. KG, Ludwigshafen, Germany Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 158, Issue 3, 1 March 2008, Pages 549–557, https://doi.org/10.1111/j.1365-2133.2007.08236.x Published: 01 March 2008